FGFR3 and cancer: The identification of the FGFR3-TACC3 fusion in various cancers, through state-of-the-art diagnostic methods such as RNA sequencing, reverse transcription polymerase chain reaction, and immunostaining, underscores its significance in the field of targeted cancer therapy.